guy jud (@jud_guy) profile picture
Joined December 2017
Photo by guy jud (@jud_guy)Photo by guy jud (@jud_guy)Photo by guy jud (@jud_guy)Photo by guy jud (@jud_guy)Photo by guy jud (@jud_guy)Photo by guy jud (@jud_guy)Photo by guy jud (@jud_guy)
guy jud retweeted
First post on substack, hope you enjoy It! $WW is a very compelling opportunity. Danke @value_invest12 for your write up! substack.com/home/post/p-185…
4
2
1
7
1,755
🚨New episode of The Eye Believe Podcast!🎙️ ESMO 2025 Highlights: Key Uveal Melanoma Trial Updates with Dr. Matt Hadfield!  📺 youtu.be/O7CnndQrecc 🎧 podbean.com/eas/pb-p4pnr-1a2… Sorry for the delay on this one! We've had all the technical difficulties today!
2
1
4
572
guy jud retweeted
Altan Ahmed (interventional radiologist at Moffitt Cancer Center) and Dr. Sid Padia (interventional radiologist at UCLA) join guest-host Dr. Kavi Krishnasamy to discuss HEPZATO $dcth “Chronic liver toxicity is pretty non existent “ “A lot of patients we are now sending them home same day after 4-6 hours.” “Most of the patients return to work in about 3 days, even if it is a physical labor job. The physical recovery gets faster with each successful procedure, hepzato number 4 compared to the 1st one, the tolerability is better.” “Liver-Dominant Metastatic Colorectal Cancer is the next unmet need that makes the most sense.” None will be easy to study, breast cancer will be even harder. Due to the lines of therapy that are currently out there. Hard to say where it would best be used. Their livers take a big hit here so definitely an opportunity. Trial settings will be best place to test it. youtu.be/FmCVAb5gYFw?si=7Ihj…
2
2
13
2,446
“It is becoming quite common” $dcth “At first it was hard to get everyone on the same page but once they were he has been amazed how successful the treatment is.” Liver full of tumors, “Sign him up for hepzato, we can take care of this he said.” Dr. Siddharth Padia is going around and teaching other institutions how to do hepzato. He can do 2 procedures in a day. What makes it complicated is the amount of people in the room that need to be trained but once they are it works great. m.youtube.com/watch?v=y93ysu…
4
25
2,972
💙 Thank you, Scottsdale! Our Lookin’ For A Cure 5K was a record-breaker! 📸 Event photos are live — free downloads: 👉 acureinsight.smugmug.com/202… 🏁 419 registered (new record!) 💰 $34,297.69 so far Thank you for supporting the OM community and making this event unforgettable! ✨
1
1
259
🚨Exciting News From Delcath!🚨 This new and interesting data may be something you wish to discuss with your medical oncologist. The Delcath press release is below, which includes a summary of the study results.  investors.delcath.com/news-r…
1
2
280
Replying to @_Biotech_iQ
Big picture $IMCR $57M rev last qtr leads to peak sales of $470M/yr $DCTH as obvious first line 85% margins $55M fixed costs $344M before tax 15x $5b $112 s/p but ramp will take 3 years. Patience and then layer on new indications 10x and proven efficacy from IHP
2
5
887
WOW!! UCSD IR team (lead by Zach Berman and Jeet Monocha) and supported by UCSD anesthesia and UCLA colleagues complete our first Hepzato case!!! Best in class patient care with a cross UC and multidisciplinary team!!! @pattymaysent @UCSDRadRes @UCSDImaging @UCSDHealth
2
2
32
1,924
guy jud retweeted
Excited to share 1 of 4 papers published/ in press on PHP. @MoffittNews was the lead institution on the international phase 3. PHP is a great treatment option for patients with OM to liver. We are now doing 4-6 PHP/ month at Moffitt! url.us.m.mimecastprotect.com….
2
2
2
958
PHP can savage patients who progress on later line therapies. But we should use it early when burden of disease is low. @MoffittNews #ACT2024
Helana Ghali presenting at @SocSurgOnc #ACT2024 the benefit of PHP 1st vs later line for OM metastatic melanoma to the liver @USFHealthMed @MoffittNews Great work Helana!!
2
5
1
13
2,285
Cancer Treatment Breakthrough Set to Print Cash Delcath Systems $DCTH could deliver a 22.4X return by 2026. ‘Rainy Man’ on the prospects for the company and why investors are hesitating… thebigscore.com/p/cancer-tre… I’m a shareholder
1
1
5
2,472
Missed this, but looks like $dcth announced first commercial shipment today. May have been part of today’s 10% move.
1
2
6
1,649
PFA's main selling point has been avoiding AEF (incidence 0.038% percent in POTTER-AF). Combined increase in embolic events and coronary spasm are surely going to nullify any safety benefit?
It is very interesting that the Stroke/TIA rate associated w/PFA is 0.57% whereas earliest studies using RFA is around 0.1% since 2019 using uninterrupted anticoagulation. Close f/u to this complication using PFA is warranted. Far more than expected. doi.org/10.1111/jce.14758
2
8
2
36
35,142
$DCTH Must read 👇 Excellent take highlighting investment thesis. I will add/expand few points as well. 1. Likely for Medicare pts, HEPZATO will be reimbursed using pass-through status, initially with a miscellaneous ZE code before being assigned a unique ZE code. So no lag for coverage. 2. S&M expenses should be modest. Among medical centers which Delcath will target 10 or so are prepared to offer HEPZATO almost immediately following approval. So very good odds of strong revenues in the first 12 mos. 3. Agree on CHOPIN data -> combining HEPZATO with systemic immunotherapy can potentially achieve promising overall disease control rates in pts that otherwise would have limited Tx options. 4. For ICC which is a large IND who failed 1st line tax, nice oppy for HEPZATO (high unmet need). Colorectal pts too and other tumors as well as mentioned.
$DCTH Thread 1 This thread will provide a detailed overview of the company’s drug pipeline and clinical results, current valuation and financial overview, Total Addressable Market (TAM) and expected Stock valuation based on TAM. As always do your due diligence.
1
2
15
12,603
STABILITY - reach - precision - safety. Stable focal contact with #RoboticEP @Stereotaxis #WeAreBack #GenesisRMN #OpenEP #Robotics @EPeeps_Bot @scrnaonline roboticep.com
2
14
52
6,423
Hear from Dr. Burkhard Hügl discussing #RoboticEP in this feature on Germany's public broadcast network SWR. Dr. Hügl & #EPeeps at St. Elisabeth Hospital Marienhaus are recognized for treating 3000 patients with cardiac arrhythmia ❤️using robotics. youtube.com/watch?v=AKc6LwnZ…
3
5
This is a fantastic video for patients and internists! @NEJM – at Paris, France
2
9
Consider the short duration of energy delivery with PFA and the consistent contact native to RMN vs. when a manual catheter might bounce off the surface (stiff catheter/moving heart). Then add potential for automation= huge potential @Stereotaxis @uazmedphx
1
2
1
10